Peking Union Medical College Hospital: Breast Neoplasms trials

The registry lists 52 Breast Neoplasms studies with Peking Union Medical College Hospital as lead sponsor. 18 are open to participants now and 0 have results posted.

Early Phase 1 5Phase 1 2Phase 2 11Phase 3 10Phase 4 1No phase 28(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Construction of a Benchmark for Breast Ultrasound AI Interpretation and Performance Evaluation of Multimodal AI ModelsRecruitingNCT07500428
• Rationale and Trial Design of PFB-03 Study: Diagnostic Performance and Clinical Application of 18F-FAPI-PET/CT for Detecting Axillary Lymph Node Metastasis in Breast Cancer Patients After Neoadjuvant TherapyNot yet recruitingNCT07012707
• Photoacoustic/Ultrasound Imaging for Breast Nodule Diagnosis, Molecular Classification, and Neoadjuvant Chemotherapy Response EvaluationRecruitingNCT06908291Not applicable
• Large Segmentation Radiotherapy ± Deep Inspiration Breath Hold(DIBH) for Left Breast CancerRecruitingNCT06660628Not applicable
• Hypofractionated Online Adaptive Radiotherapy of Breast CancerRecruitingNCT06568705Phase 2
• Application of 68GA-labeled CD73 Targeting Probe PET/CT Imaging in the Diagnosis of Breast CancerRecruitingNCT06411678Early Phase 1
• 99mTc-ABH2 SPECT/CT in Breast CancerRecruitingNCT06194565Not applicable
• 99mTc-MY6349 SPECT/CT Imaging in Trop2-positive Triple-negative Breast CancerRecruitingNCT06104085Not applicable
• The Choice of Treatment Methods and Efficacy of LABCRecruitingNCT06080620Not applicable
• Pyrotinib Plus Capecitabine for Adjuvant Treatment of HER2 Positive Early-stage Breast CancerRecruitingNCT06035016
• Dalpiciclib With Endocrine Therapy for Advanced Breast Cancer After CDK4/6 Inhibitor Failure (DAWNA-FES)RecruitingNCT05861830Phase 3
• Optical Surface Monitoring Technology-Guided Large-Segment Radiotherapy for Breast CancerRecruitingNCT05804916Phase 2/3
• Prospective Research for Elderly (≥65 Years Old) Early Breast Cancer PatientsRecruitingNCT05680194
• Nab-paclitaxel in Combination With Pyrotinib in Postoperative Adjuvant Therapy for HER2-positive Breast CancerNot yet recruitingNCT04659499Phase 2
• A Prospective Cohort Study Comparing Disparity in Surgical Procedure (Wide Local Excision Only vs Any Other Surgery Procedures) Among the Elderly Breast Cancer PatientsNot yet recruitingNCT04426136
• Evaluation of Prognostic Monitoring for Young Breast Cancer PatientsRecruitingNCT04145986
• Evaluation of Prognostic Monitoring for Breast Cancer Patients With Recurrence and Metastasis After SurgeryRecruitingNCT04145973
• Evaluation of Prognostic Monitoring for Women Who Have Completed Standard Treatment for Breast CancerRecruitingNCT04145960
• Health Belief Model-Based Survey on Breast Self-Examination Awareness and Practice Among Community-Dwelling Middle-Aged and Older WomenActive, not recruitingNCT07149636
• Survival of BCS vs Mx in Asymptomatic Screen-detected NPBCCompletedNCT06103032
• 99mTc-MIRC213 SPECT/CT for the Detection of HER2-positive Breast CancerStatus unknownNCT05622240Early Phase 1
• 68Ga PET/CT Imaging in Breast Cancer PatientsStatus unknownNCT05622227Phase 1/2
• Characterizing Breast Cancer With 18F-FES PET/CTStatus unknownNCT05613270Not applicable
• Characterizing Breast Cancer With Al18F-NOTA-FAPI-04 PET/CT (PFB-02)Active, not recruitingNCT05574920Not applicable
• Characterizing Breast Cancer With 68Ga-FAPI PET/CT (PFB-01)Active, not recruitingNCT05574907Not applicable
• An Innovative Smartphone Application for Adverse Event Management During Breast Cancer Adjuvant ChemotherapyStatus unknownNCT05258461Not applicable
• Clinical Study of Vascular Imaging Evaluation of Computed Tomography Photoacoustic Breast Imaging SystemStatus unknownNCT04825444
• A Comparative Study of Mammography and Ultrasound for Breast Cancer Screening and Early DiagnosisStatus unknownNCT04429269
• 99mTc-HPArk2 SPECT/CT for the Detection of HER2-positive Breast CancerCompletedNCT04267900Early Phase 1
• Evaluation of Prognostic Monitoring for Triple Negative Breast Cancer PatientsStatus unknownNCT04145947
• Clinical Application of ctDNA in Early Screening of Breast CancerStatus unknownNCT03973034
• Survival Benefits of Statins in Breast Cancer PatientsStatus unknownNCT03971019Phase 3
• Pyrotinib Combined With Trastuzumab and AI in the First-line Treatment of HER2 Positive/ HR Positive MBCStatus unknownNCT03910712Phase 2
• Application of Deep-learning and Ultrasound Elastography in Opportunistic Screening of Breast CancerCompletedNCT03851497
• Clinical Application of CTC in Operable Breast Cancer PatientsStatus unknownNCT03842176
• 99mTc Labelled Affibody SPECT/CT Imaging for Breast Cancer HER2 CharacterizationCompletedNCT03546478Early Phase 1
• 68Ga-NOTA-RM26 PET/CT in Breast Tumor PatientsStatus unknownNCT03347864Early Phase 1
• A Randomized Controlled Trial of HER-2 Positive Breast Cancer Patients Treated With Lapatinib vs HerceptinStatus unknownNCT03085368Phase 2/3
• Standard Chemotherapy Followed by Capecitabine as Prolonged Postoperative Adjuvant Treatment for Breast CancerStatus unknownNCT02842099Phase 2
• X Versus Placebo as Postoperative Adjuvant Treatment for Elder Breast CancerStatus unknownNCT02838238Phase 2
• DA Versus DAC as Postoperative Adjuvant Treatment for Early-stage Breast CancerCompletedNCT02838225Phase 2
• Clinical Application of CTDNA in Operable Breast Cancer PatientsStatus unknownNCT02797652
• Dual Integrin αvβ3 and GRPR Targeting PET Imaging in Breast Cancer PatientsStatus unknownNCT02749019Phase 1
• Gonadotropin-Releasing Hormone Agonist for the Preservation of Ovarian Function During Chemotherapy in Premenopausal Breast CancerCompletedNCT02483767Phase 3
• Ultrasound-based Breast Cancer Screening in Chinese WomenStatus unknownNCT02268643
• Adjuvant Toremifene With or Without Goserrelin in Premenopausal Women With Stage I-IIIA, Hormonal Receptor Positive Breast Cancer Accompanied With or Without Chemotherapy Induced AmenorrhoeaStatus unknownNCT02132390Phase 3
• Prognostic Evaluation of Changing Endocrine Therapy in Women With Breast CancerStatus unknownNCT02097459Phase 3
• Adjuvant Endocrine Therapy for Estrogen Receptor-beta Positive Triple Negative Breast CancerStatus unknownNCT02089854Phase 4
• Ultrasound and Mammography for Screening Breast Cancer in Chinese WomenCompletedNCT01880853Not applicable
• AX Versus AC as Adjuvant Treatment for Node-Negative Breast CancerStatus unknownNCT01415336Phase 2/3
• Trastuzumab Administered Concurrently or Sequentially to Anthracycline-containing Adjuvant Regimen for Breast CancerCompletedNCT01413828Phase 2/3
• TAC Versus TCX as Adjuvant Treatment for High-risk Her2-Negative Breast CancerCompletedNCT01354522Phase 3